ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden
· Delayed Price · Currency is SEK 27.45
-0.20 (-0.72%)
Jul 9, 2025, 2:56 PM CET
STO:EXPRS2 Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 3.42 | 3.01 | 7.05 | 5.09 | 12.23 | 5.26 | Upgrade
|
Other Revenue | 5.8 | 4.81 | 1.75 | 1.06 | 1.5 | 10 | Upgrade
|
| 9.22 | 7.83 | 8.8 | 6.15 | 13.73 | 15.26 | Upgrade
| |
Revenue Growth (YoY) | 18.76% | -11.07% | 43.07% | -55.21% | -10.04% | 10.37% | Upgrade
|
Cost of Revenue | 5.23 | 5.68 | 3.65 | 5.08 | 7.51 | 6.1 | Upgrade
|
Gross Profit | 4 | 2.14 | 5.15 | 1.07 | 6.22 | 9.16 | Upgrade
|
Selling, General & Admin | 45 | 41.54 | 58.1 | 56.14 | 35.89 | 37.22 | Upgrade
|
Research & Development | 23.54 | 26.66 | 51.42 | 71.32 | 9.82 | 0.22 | Upgrade
|
Operating Expenses | 70.18 | 69.84 | 111.12 | 128.68 | 47.51 | 40.36 | Upgrade
|
Operating Income | -66.18 | -67.7 | -105.97 | -127.61 | -41.3 | -31.2 | Upgrade
|
Interest Expense | -1.12 | -0.73 | -0.5 | -0.87 | - | -3.53 | Upgrade
|
Interest & Investment Income | 1.46 | 1.71 | 1.91 | 1.9 | - | - | Upgrade
|
Earnings From Equity Investments | 22.15 | 22.15 | 4.59 | - | 0.67 | -0.19 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | - | 0.21 | - | Upgrade
|
EBT Excluding Unusual Items | -43.69 | -44.56 | -99.97 | -126.58 | -40.42 | -34.92 | Upgrade
|
Other Unusual Items | - | - | - | - | -7.1 | - | Upgrade
|
Pretax Income | -43.69 | -44.56 | -99.97 | -126.58 | -47.52 | -34.92 | Upgrade
|
Income Tax Expense | -9.07 | -8.53 | -8.57 | -7.98 | -3.59 | -3.21 | Upgrade
|
Net Income | -34.63 | -36.04 | -91.4 | -118.61 | -43.93 | -31.71 | Upgrade
|
Net Income to Common | -34.63 | -36.04 | -91.4 | -118.61 | -43.93 | -31.71 | Upgrade
|
Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
Shares Change (YoY) | 64.06% | 46.56% | 31.49% | 20.02% | 68.61% | 31.36% | Upgrade
|
EPS (Basic) | -17.02 | -21.31 | -79.22 | -135.18 | -60.09 | -73.14 | Upgrade
|
EPS (Diluted) | -17.02 | -21.31 | -79.22 | -135.18 | -60.09 | -73.14 | Upgrade
|
Free Cash Flow | -55.81 | -34.8 | -102.9 | -100 | -46.36 | -19.06 | Upgrade
|
Free Cash Flow Per Share | -27.43 | -20.58 | -89.19 | -113.97 | -63.42 | -43.96 | Upgrade
|
Gross Margin | 43.34% | 27.40% | 58.55% | 17.38% | 45.28% | 60.02% | Upgrade
|
Operating Margin | -717.51% | -865.11% | -1204.28% | -2074.89% | -300.78% | -204.39% | Upgrade
|
Profit Margin | -375.38% | -460.55% | -1038.77% | -1928.54% | -319.92% | -207.78% | Upgrade
|
Free Cash Flow Margin | -605.05% | -444.70% | -1169.47% | -1625.97% | -337.66% | -124.88% | Upgrade
|
EBITDA | -64.54 | -66.05 | -104.37 | -126.35 | -39.8 | -28.28 | Upgrade
|
EBITDA Margin | - | - | - | - | -289.87% | -185.29% | Upgrade
|
D&A For EBITDA | 1.64 | 1.64 | 1.6 | 1.25 | 1.5 | 2.92 | Upgrade
|
EBIT | -66.18 | -67.7 | -105.97 | -127.61 | -41.3 | -31.2 | Upgrade
|
EBIT Margin | - | - | - | - | - | -204.39% | Upgrade
|
Revenue as Reported | 9.22 | 7.83 | 8.8 | 6.15 | 13.73 | 15.26 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.